AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasisJino Park, William Tse, Gang Huang et al.|Oncotarget|2015Cited by 40
MLLT11/AF1q boosts oncogenic STAT3 activity through <i>Src</i>-PDGFR tyrosine kinase signalingJino Park, William Tse|Oncotarget|2016Cited by 31
Clofarabine In Combination with Cyclophosphamide for Treatment of Relapsed/Refractory Acute Leukemia In Adult PatientsBobby Chawla, Aaron Cumpston, Abraham S. Kanate et al.|Blood|2010Cited by 1
Response to Induction Chemotherapy with Novel Agents Does Not Predict Outcomes of Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell TransplantationSalman Osman, Sayed Mehdi Hamadani, Abraham S. Kanate et al.|Blood|2010Cited by 0
In Vivo T-Cell Depletion (TCD) Does Not Improve Rates of Graft-Versus-Host Disease (GVHD) and Transplantation Outcomes in Patients Undergoing Peripheral Blood Allogeneic Hematopoietic Cell Transplant (AHCT)Abraham S. Kanate, Mehdi Hamadani, Samira Osman et al.|Transplantation and Cellular Therapy|2011Cited by 0